HVTN

The HIV Vaccine Trials Network (HVTN) is a global leader in HIV prevention. Based in Seattle and operating across four continents, HVTN pioneers vaccinology, immunology, and clinical trials for HIV, tuberculosis, and COVID-19. With over 70 study sites, the network has conducted 100+ clinical trials and awarded 95+ scholar grants to foster the next generation of HIV prevention researchers.

HVTN's mission is to develop a safe and effective HIV vaccine, and its work is backed by over two decades of expertise. The network's collaborative approach involves participants, volunteers, communities, industry, academia, and governments, all working towards a common goal. Recent initiatives include the Research and Mentorship Program (RAMP), providing mentorship and funding to minority medical students.

HVTN's impact is felt internationally, with thousands of volunteers participating in HIV vaccine trials. Their pioneering work is advancing the fields of immunization and prevention, offering hope for a future without AIDS